Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,035
datasets available to search
ShareScore release 0.9.0
Dataset results
1,035 results for “cancer invasion”
Gene expression profiling of invasive breast cancer events from the tamoxifen prevention trial
GEO Series GSE12665. Homo sapiens. 108 samples. Type: Expression profiling by array.
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression
GEO Series GSE80182. Homo sapiens. 9 samples. Type: Expression profiling by high throughput sequencing.
IGF2BP3 controls cancer cell invasiveness by modulation RISC function
GEO Series GSE79147. Homo sapiens. 26 samples. Type: Expression profiling by high throughput sequencing; Other; Non-coding RNA profiling by high throughput sequencing.
Naturally-occurring canine invasive urothelial carcinoma harbors luminal and basal transcriptional subtypes found in human muscle invasive bladder cancer
GEO Series GSE110661. Canis lupus familiaris. 33 samples. Type: Expression profiling by high throughput sequencing.
Data from: Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer
The prognostic value of repeat transurethral resection of bladder tumor (TURBT) in patients with diagnosed high-risk, non-muscle-invasive bladder cancer (NMIBC) was investigated. We retrospectively reviewed the medical records of patients treated from October 2004 to December 2013 at Seoul National University who underwent repeated TURBT within 2–6 weeks after an initial resection. The study enrolled patients who had been diagnosed with NMIBC at both the initial and repeat TURBT; patients with muscle-invasive tumors on repeat TURBT were excluded. We used stepwise multivariate Cox regression models stratified by study to assess the independent effects of the predictive factors and estimated hazard ratios (HRs) from the Cox models. We investigated a total of 198 patients who were diagnosed with high-risk NMIBC. In logistic regression analyses, number of bladder tumors (2–7: OR, 2.319; 8≤: OR, 3.353; p<0.05), initially high tumor grade (OR, 2.435; p = 0.040), and presence of carcinoma in situ lesion (OR, 3.639; p = 0.017) correlated with residual tumor in the repeated-TURBT specimen. T1 stage in repeated-TURBT significantly correlated with recurrence (HR, 1.837; p = 0.010) and progression (HR, 2.806; p = 0.029) in multivariate analysis. The high grades of tumors in repeated-TURBT also significantly correlated with progression but not recurrence in the multivariate analysis (HR 2.152; p = 0.008). In this study, the pathologic findings in repeated-TURBT correlated with recurrence and progression in high-risk NMIBC. Repeated-TURBT is valuable because it can predict the recurrence and progression of high-risk NMIBC in addition to obtaining accurate pathologic findings.
MYC enhancer invasion promotes prognostic cancer type-specific gene programs through an epigenetic switch
<p>Pre-processed data for reproduction of the figure in <strong>MYC enhancer invasion promotes prognostic cancer type-specific gene programs through an epigenetic switch</strong></p>
Safety and Efficacy of FE 999326 Administered Intravesically to Japanese Subjects With High-grade, BCG Unresponsive, Non-muscle Invasive Bladder Cancer (NMIBC)
ClinicalTrials.gov study NCT05704244. IPD Sharing: NO. Countries: 1. Publications: 0.
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
ClinicalTrials.gov study NCT04586959. IPD Sharing: NO. Countries: 1. Publications: 0.
PF-07225570 Alone or in Combination With an Anti-PD-1 Antibody in Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)
ClinicalTrials.gov study NCT05259397. IPD Sharing: NO. Countries: 2. Publications: 0.
Urine-based Molecular Testing vs Cystoscopy for Surveillance of Nonmuscle Invasive Bladder Cancer (NMIBC)
ClinicalTrials.gov study NCT06126796. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A New Scoring System for Perineural and Vascular Invasion in Pancreatic Cancer
ClinicalTrials.gov study NCT04024358. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Novel Pathway to Detect Muscle-invasive Bladder Cancer Based on Integrated Clinical Features and VI-RADS Score on MRI
ClinicalTrials.gov study NCT06807008. IPD Sharing: NO. Countries: 1. Publications: 0.
The Potential Role Of MicroRNA-155 And Telomerase Reverse Transcriptase In Diagnosis Of Non-Muscle Invasive Bladder Cancer And Their Pathological Correlation
ClinicalTrials.gov study NCT03591367. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer
ClinicalTrials.gov study NCT00002579. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Non-invasive Identification of Colorectal Cancer and Adenomas in Early Stages
ClinicalTrials.gov study NCT05445570. IPD Sharing: NO. Countries: 1. Publications: 0.
Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ or Invasive Breast Cancer
ClinicalTrials.gov study NCT00054301. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT05951179. IPD Sharing: NO. Countries: 6. Publications: 0.
Continuous or Intermittent Extension of Adjuvant Pyrotinib for Invasive HER2-positive Breast Cancer
ClinicalTrials.gov study NCT05910398. IPD Sharing: NO. Countries: 1. Publications: 0.
Genetic Susceptibility to Tumor Recurrence and Progression in Patients With Non-Muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT00582387. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of HX008 for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT04738630. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.